Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-025180)

Filing Details

Accession Number:: 0001209191-22-025180
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2022-04-21 16:50:22
Reporting Period:: 2021-08-16

Accepted Time:: 2022-04-21 16:50:22
Original Submission Date:: 2021-08-17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1819411	Gain Therapeutics Inc.	GANX	()	4/A

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1313876	I Eric Richman	C/O Gain Therapeutics, Inc. 4800 Montgomery Lane, Suite 220 Bethesda MD 20814	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-08-16	4,922	$7.87	216,820	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The original Form 4 filed on August 17, 2021 incorrectly listed the transaction code at "M" instead of "P".